TBA The Biotechnology Initiative

The Voice of Bioscience in Ontario



Board of Directors

TBI is governed by a Board of Directors that represent Ontario’s pharmaceutical and biotechnology industry. These elected directors provide guidance and set policy for TBI, facilitating The Biotechnology Intiative’s strong voice in advocacy and economic development in Ontario.


TBI Board of Directors, effective May 2007

Grant Tipler RBC Royal Bank
Karen Atkinson Ernst & Young LLP
Matt Buist City of Toronto, Office of Economic Dev.
Geoff Collett Astrazeneca Canada Inc.
Jeffrey Graham Borden Ladner Gervais LLP
Greg Hines ArcticDx Inc.
Darlene Homonko Golden Horseshoe Venture Forum
John Kelly MaRS Landing
Jason Locklin Sanofi Pasteur Limited
Tim McTiernan The Innovations Group University of Toronto
Lorne Meikle AFFERENCE Therapeutics
Anita Nador McCarthy Tetrault
Allan O'Dette GlaxoSmithKline Canada
Dale Patterson Canadian Medical Discoveries Fund
Stan Shapson York University
Adi Treasurywala ArrowCan Partners